牛牛AI助手已提取核心信息先声药业集团2025年上半年实现收入35.85亿元人民币，同比增长15.1%。其中创新药业务收入27.76亿元，占总收入77.4%，同比增长26.0%。归属于公司股东净利润6.04亿元，同比增长32.2%。经调整后净利润6.51亿元，同比增长21.1%。从业务领域来看，神经科学领域收入12.49亿元，占总收入34.8%，同比增长37.3%；抗肿瘤领域收入8.74亿元，占...
Source Link牛牛AI助手已提取核心信息先声药业集团2025年上半年实现收入35.85亿元人民币，同比增长15.1%。其中创新药业务收入27.76亿元，占总收入77.4%，同比增长26.0%。归属于公司股东净利润6.04亿元，同比增长32.2%。经调整后净利润6.51亿元，同比增长21.1%。从业务领域来看，神经科学领域收入12.49亿元，占总收入34.8%，同比增长37.3%；抗肿瘤领域收入8.74亿元，占...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.